Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals

Journal of Urology

Volumn 163, Issue 3, 2000, Pages 802-805

  Obiezu, Christina V ^b   Giltay, Erik J ^b   Magklara, Angeliki ^b   Scorilas, Andreas ^b   Gooren, Louis ^b   Yu, H E ^b   Diamandis, Eleftherios P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

Androgen antagonists; Cyproterone acetate; Kallikrein; Prostate specific antigen; Transsexualism

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; PROSTATE SPECIFIC ANTIGEN; TISSUE KALLIKREIN;

ARTICLE; GENE CONTROL; HORMONAL THERAPY; HUMAN; KALLIKREIN URINE LEVEL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SYNTHESIS INHIBITION; TRANSSEXUALISM; TUMOR VOLUME;

EID: 0033962574     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67808-1     Document Type: Article

References (27)

1. Breul, J., Pickl, U. and Hartung, R.: Prostate-specific antigen in urine. Eur Urol, 26: 18, 1994
2. Iwakiri, J., Grandbois, K., Wehner, N. et al: An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by periurethral glands. J Urol, 149: 783, 1993
3. Diamandis, E. P. and Yu, H.: New biological functions of prostate-specific antigen? J Clin Endocrinol Metab, 80: 1515, 1995
4. Diamandis, E. P. and Yu, H.: Nonprostatic sources of prostate-specific antigen. Urol Clin North Am, 24: 275, 1997
5. Collins, A. T., Zhiming, B., Gilmore, K. et al: Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. J Endocrinol, 143: 269, 1994
6. Zarghami, N., Grass, L. and Diamandis, E. P.: Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer, 75: 579, 1997
7. Horwitz, K. B., Jackson, T. A., Bain, D. L. et al: Nuclear receptor coactivators and corepressors. Mol Endocrinol, 10: 1167, 1996
8. Schuur, E. R., Henderson, G. A., Kmetec, L. A. et al: Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem, 271: 7043, 1996
9. Cleutjens, K. B., van der Korput, H. A. and Ehren-van Eekelen, C. C.: A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate specific-antigen gene in humans. Mol Endocrinol, 11: 1256, 1997
10. Cleutjens, K. B., van der Korput, H. A., Ehren-van Eekelen, C. C. et al: An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol, 11: 148, 1997
11. Cleutjens, K. B., van Eekelen, C. C., van der Korput, H. A. et al: Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem, 271: 6379, 1996
12. Breul, J., Pickl, U. and Schaff, J.: Extraprostatic production of prostate specific antigen is under hormonal control. J Urol, 157: 212, 1997
13. Wolf, D. A., Herzinger, T., Hermeking, H. et al: Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol Endocrinol, 7: 924, 1993
14. de Vries, C. P., Gooren, L. J. and van der Veen, E. A.: The effect of cyproterone acetate alone and in combination with ethinylestradiol on the hypothalamic pituitary adrenal axis, prolactin and growth hormone release in male-to-female transsexuals. Horm Metab Res, 18: 203, 1986
15. Wolf, D. A., Schulz, P., Fittler, F.: Transcriptional regulation of prostate kallikrein-like genes by androgen. Mol Endocrinol, 6: 753, 1992
16. Wakeling, A. E., Furr, B. J., Glen, A. T. et al: Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens. J Steroid Biochem, 15: 355, 1981
17. Gooren, L.: Androgens and estrogens in their negative feedback action in the hypothalamo-pituitary-testis axis: site of action and evidence of their interaction. J Steroid Biochem, 33: 757, 1989
18. Akakura, K., Bruchovsky, N., Goldenberg, S. L. et al: Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer, 71: 2782, 1993
19. Diamond, T., Campbell, J., Bryant, C. et al: The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy. Cancer, 83: 1561, 1998
20. Goldenberg, S. L., Bruchovsky, N., Rennie, P. S. et al: The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma. J Urol, 140: 1460, 1988
21. Stepanov, V. N., Goriunov, V. G., Chechenin, M. G. et al: Cyproterone acetate (Androcur-depo) in the treatment of inoperable prostatic cancer. Urol Nefrol (Mosk), 6: 33, 1995
22. Ferguson, R. A., Yu, H., Kalyvas, M. et al: Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite Immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem, 42: 675, 1996
23. Black, M. H., Magklara, A., Obiezu, C. V. et al: Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Clin Chem, 45: 790, 1999
24. de Voogt, H. J., Rao, B. R., Geldof, A. A. et al: Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate. Prostate, 11: 305, 1987
25. Gooren, L.: The endocrinology of transsexualism: a review and commentary. Psychoneuroendocrinology, 15: 3, 1990
26. Stenman, U. H.: New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease. Clin Chem, 45: 753, 1999
27. Pinsky, L., Kaufman, M., Gil-Esteban, C. et al: Regulation of the androgen receptor in human genital skin fibroblasts, with a review of sex steroid receptor regulation by homologous and heterologous steroids. Can J Biochem Cell Biol, 61: 770, 1983